Expression of Scavenger Receptor CD36 in Chronic Renal Failure Patients
The DOI matches its Crossref record.
Abstract
Background: Patients with chronic renal failure (CRF) are at increased risk of atherosclerosis development. One of the major steps in pathogenesis of atherosclerosis is formation of foam cells. Scavenger receptor CD36 is among the major receptors for oxidized low density lipoproteins (oxLDL) and therefore it plays a crucial role in foam cell formation. The aim of the present study was to investigate the expression of CD36 on blood monocytes of CRF patients. Methods: Expression of CD36 on blood monocytes of CRF patients treated with hemodialysis (HD), peritoneal dialysis (PD), those not yet on dialysis (predialysis), and controls was assessed with the use of flow cytometry. Additionally, the major lipid peroxidation markers, malondialdehyde (MDA) and 4‐hydroxyalkenals (HAE), were measured. Further, impact of treatment with HMG‐CoA reductase inhibitors (statins) on CD36 expression in CRF patients was evaluated. Results: Expression of monocyte CD36, measured as mean fluorescence intensity (MFI) was significantly higher in HD and PD patients, when compared to controls without renal insufficiency (respectively: 1011 ± 288 and 1000 ± 309 vs. 710 ± 313; P < 0.01 for both groups). This was not the case in predialysis group (828 ± 363 vs. 710 ± 313). Higher concentrations of lipid peroxidation indicators, MDA and HAE were observed in all three subgroups of CRF patients (2.1 ± 0.51, 2.02 ± 0.27, and 1.81 ± 0.53 µm in HD, PD, and predialysis group, respectively, vs. 1.13 ± 0.59 µm in controls; P < 0.01). Patients treated with statins showed significantly lower CD36 expression than patients without statin therapy. Conclusions: The present study, for the first time, demonstrates increased expression of CD36 scavenger receptor in CRF patients. This may be a possible risk factor for accelerated atherogenesis observed in this group of patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Aspects of Immune Dysfunction in End-stage Renal Disease
Kato, S., Chmielewski, M., Honda, H., Pecoits-Filho, R., Matsuo, S., Yuzawa, Y., Tranaeus, A., Stenvinkel, P., & Lindholm, B. (2008) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00950208 · Cited by 1,087
Self-citationImmune cell dysfunction and inflammation in end-stage renal disease
Betjes, M. G. H. (2013) · Nature Reviews Nephrology · doi:10.1038/nrneph.2013.44 · Cited by 542
Serum Trimethylamine-N-Oxide is Elevated in CKD and Correlates with Coronary Atherosclerosis Burden
Stubbs, J. R., House, J. A., Ocque, A. J., Zhang, S., Johnson, C., Kimber, C., Schmidt, K., Gupta, A., Wetmore, J. B., Nolin, T. D., et al. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014111063 · Cited by 450
Immune Dysfunction and Risk of Infection in Chronic Kidney Disease
Syed-Ahmed, M., & Narayanan, M. (2019) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2019.01.004 · Cited by 411
Chronic Kidney Disease as Oxidative Stress- and Inflammatory-Mediated Cardiovascular Disease
Podkowińska, A., & Formanowicz, D. (2020) · Antioxidants · doi:10.3390/antiox9080752 · Cited by 356
Metadata
- Authors
- Chmielewski, M., Bryl, E., Marzec, L., Aleksandrowicz, E., Witkowski, J. M., & Rutkowski, B.
- Venue
- Artificial Organs
- Publisher
- Wiley
- Published
- 2005-07-27
- Volume
- 29
- Issue
- 8
- Pages
- 608-614
- ISSN
- 0160-564X (ISSN-L)
- 1525-1594
- OpenAlex
- W1965222038
- Cited by
- 48
- References
- 0
- FWCI
- 0.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Expression of Scavenger Receptor CD36 in Chronic Renal Failure Patients. https://app.cochat.ai/papers/10.1111/j.1525-1594.2005.29097.x
- The paper
- Chmielewski, M., Bryl, E., Marzec, L., Aleksandrowicz, E., Witkowski, J. M., & Rutkowski, B. (2005). Expression of Scavenger Receptor CD36 in Chronic Renal Failure Patients. Artificial Organs. https://doi.org/10.1111/j.1525-1594.2005.29097.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.